
Cue Biopharma, Inc. — Investor Relations & Filings
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of injectable, engineered biologics to selectively modulate the human immune system. The company's proprietary platform creates therapeutics designed to mimic natural immune signals to precisely engage, expand, and activate specific, disease-relevant T cells. This targeted approach is being applied to develop immunotherapies for the treatment of cancer and autoimmune diseases, with the goal of restoring immune balance and providing effective treatments for serious conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEF 14A | 2026-05-21 | English | |
| 8-K | 2026-05-14 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-22 | English | |
| 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-13 | English | |
| 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46735308 | DEF 14A | 2026-05-21 | English | ||
| 46257334 | 8-K | 2026-05-14 | English | ||
| 46274638 | 10-Q | 2026-05-14 | English | ||
| 35251607 | 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-22 | English | ||
| 34434499 | 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-13 | English | ||
| 33706784 | 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-07 | English | ||
| 32965297 | S-3 - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-03-17 | English | ||
| 32895721 | 8-K - CUE BIOPHARMA, INC. (0001645460) (Filer) | 2026-02-18 | English | ||
| 31086230 | 8-K Filing | 2026-02-12 | English | ||
| 12882965 | 4 | 2026-01-06 | English | ||
| 12882966 | 4 | 2026-01-06 | English | ||
| 12882967 | 4 | 2026-01-06 | English | ||
| 12882968 | 4 | 2026-01-06 | English | ||
| 12882969 | 4 | 2026-01-06 | English | ||
| 12882970 | 4 | 2026-01-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cellectar Biosciences, Inc.
Clinical-stage biopharma developing targeted cancer treatme…
|
CLRB | US | Manufacturing |
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
|
Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectio…
|
299660 | KR | Manufacturing |
|
Cellromax Science Co., Ltd.
Researches and develops health foods, derma-cosmetics, and …
|
471820 | KR | Manufacturing |
|
CellSeed Inc.
Develops and commercializes cell sheet engineering for rege…
|
7776 | JP | Manufacturing |
|
Celltrion, Inc.
Biopharmaceutical firm developing biosimilars for autoimmun…
|
068270 | KR | Manufacturing |
|
Celltrion Pharm Inc.
Manufactures and supplies chemical pharmaceuticals and bios…
|
068760 | KR | Manufacturing |
|
CELLUMED CO., LTD.
Develops and manufactures medical devices, tissue grafts, a…
|
049180 | KR | Manufacturing |
|
Celon Pharma S.A.
An integrated pharmaceutical company researching and manufa…
|
CLN | PL | Manufacturing |
|
Celularity Inc
Develops allogeneic cell therapies and biomaterials from th…
|
CELU | US | Manufacturing |
Cue Biopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34525/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34525 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34525 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34525 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34525}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cue Biopharma, Inc. (id: 34525)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.